您的位置: 首页 > 农业专利 > 详情页

Bicycle non bicycle derivatives as bromine domain inhibitors
专利权人:
ORION CORPORATION
发明人:
ABBINENI, Chandrasekhar,SASMAL, Sanjita,SAMAJDAR, Susanta,HOSAHALLI, Subramanya
申请号:
PE2016001002
公开号:
PE20161021A1
申请日:
2015.01.06
申请国别(地区):
PE
年份:
2016
代理人:
摘要:
It refers to a bicycle non bicycle derivative, where: Dial line is a simple or double link; X is C, C (o),Where n or C and N may be replaced; L1 is a direct link or a link selected from NH.-NHC(O)-O-NHS(O)2-;L2 is from C (o)it is life.Among other things, C1 is a single ring composed of 5-6 members, including 1-4 heteromorphisms selected from n, NH, O-C (o).Cy2 is a single ring, consisting of 4-12 members, including 0-3 heterogeneity selected from n, NH, or s; R1 is hydrogen, tar, etc.; R2 and R3 are hydrogen, tar or combined to form an oxo group; R4 is hydrogen, tar, etc.; n is 1 or 2. The most popular compounds are: 4 - (4-chlorobenzene) - 7 - (3,5-dimethylisocyanxazol-4-il) - 6-methoxy-3,4-dihydro-benzofuran [b] [1,4] oxygen, 6 - (3,5-dimethylisocyanxazol-4-il) - 7-methoxy-1 - ((5-methoxypyridine-2-il) a) quine-2 (1H) ona. He also mentioned a pharmacology composer and a therapeutic approach. These compounds are bromine control inhibitors (BRD) that can be used to treat autoimmune diseases.Inflammation or cancerSe refiere a derivados heterociclicos biciclicos de formula I, donde: la linea punteada es un enlace simple o doble; X es C, C(O), N u O en donde C y N pueden estar sustituidos; L1 es un enlace directo o un ligador seleccionado de NH-, -NHC(O)- o –NHS(O)2-; L2 es un ligador seleccionado de –C(O)-, S(O)2-, entre otros; Cy1 es un anillo monociclico de 5-6 miembros que contiene 1-4 heteroatomos seleccionados de N, NH, O o –C(O)-; Cy2 es un anillo monociclico de 4-12 miembros que contiene 0-3 heteroatomos seleccionados de N, NH, O o S; R1 es hidrogeno, alquilo, entre otros; R2 y R3 son hidrogeno, alquilo o juntos forman un grupo oxo; R4 es hidrogeno, alquilo, entre otros; n es 1 o 2. Son compuestos preferidos: 4-(4-clorobencil)-7-(3,5-dimetilisoxazol-4-il)-6-metoxi-3,4-dihidro-2H-benzo[b][1,4]oxazina, 6-(3,5-dimetilisoxazol-4-il)-7-metoxi-1-((5-metoxipiridin-2-il)metil)quinolin-2(1H)ona; entre otros. Tambien se refiere a una composicion farmaceutica y a un metod
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充